Zealand Pharma A/s Stock
Zealand Pharma A/s Stock
Zealand Pharma A/s gained 0.250% compared to yesterday.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Zealand Pharma A/s stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Zealand Pharma A/s in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Zealand Pharma A/s vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Zealand Pharma A/s | 0.250% | 7.675% | 8.637% | 0.252% | -31.588% | 50.412% | 70.179% |
| Saniona AB | -2.030% | -2.273% | 2.381% | 55.355% | -37.226% | 57.386% | -33.111% |
| Ocuphire Pharma Inc. | - | -2.994% | -9.497% | 248.762% | 92.628% | -14.058% | -22.857% |
| NanoViricides Inc. | -3.100% | -6.716% | 7.759% | -6.015% | 34.409% | 0.000% | -62.029% |
News
Why Rocket Lab Stock Just Jumped
Rocket Lab Corporation (NASDAQ: RKLB) jumped 9.5% on Friday. The S&P 500 and the Nasdaq Composite were up 0.6% and 1.2%, respectively.
Shares of the rocket and satellite manufacturer were lifted by
Aurora Cannabis Shareholders Approve Board as Fiscal 2026 Results Beat Outlook
Key Points
- Interested in Aurora Cannabis Inc.? Here are five stocks we like better.
- Shareholders approved all proposals, including a five-member board, the election of Aurora’s director
Beauty Health Q2 Earnings Call Highlights
Key Points
- Interested in The Beauty Health Company? Here are five stocks we like better.
- Second-quarter results were mixed: Revenue fell 7.8% year over year to $72.1 million, pressured by